Kirk Heyne - Concepedia

Author

Kirk Heyne

Methodist Hospital

Also Known As

K H Heyne, K Heyne, K. Heyne, Kirk Heyne

Publications

868

Citations

H-Index

Concepts

All Affiliations

Methodist Hospital The University of Texas MD Anderson Cancer Center Methodist Hospital Houston Methodist Cornell University

About

Kirk Heyne is an author at Methodist Hospital specializing in medicine, radiation oncology, and pathology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	2	2	304
2	Pathology	2	2	304
3	Hepatology	1	1	283
4	Immunology	1	1	21
5	Surgical Oncology	1	1	283

Kirk Heyne

Publications

766

Citations

H-Index

Page 1

	Year	Citations
Liver transplantation for locally advanced intrahepatic cholangiocarcinoma treated with neoadjuvant therapy: a prospective case-series Keri E. Lunsford, Milind Javle, Kirk Heyne, The Lancet. Gastroenterology & hepatology Surgical OncologyHepatologyNeoadjuvant TherapyMedicineHepatobiliary Tumor	2018	283
p53 Expression: Predicting Recurrence and Second Primary Tumors in Head and Neck Squamous Cell Carcinoma Dong M. Shin, Jack Lee, Scott M. Lippman, JNCI Journal of the National Cancer Institute	1996	187
Survival following liver transplantation for locally advanced, unresectable intrahepatic cholangiocarcinoma Robert McMillan, Milind Javle, Sudha Kodali, American Journal of Transplantation	2021	104
The incidence of second primary tumors in long-term survivors of small-cell lung cancer. Kirk Heyne, Scott M. Lippman, J. Jack Lee, Journal of Clinical Oncology	1992	93
Outcomes of Liver Transplantation for Hepatocellular Carcinoma Beyond the University of California San Francisco Criteria: A Single-center Experience David W. Victor, Howard Monsour, Maha Boktour, Transplantation	2019	35
Transarterial Chemoembolization (TACE) Plus Sorafenib Compared to TACE Alone in Transplant Recipients with Hepatocellular Carcinoma: An Institution Experience Maen Abdelrahim, David W. Victor, Abdullah Esmail, Cancers	2022	32
Promising new treatments for pancreatic cancer in the era of targeted and immune therapies. Ahmed Elaileh, Ashish Saharia, Lucy Potter, PubMed ImmunologyPathologyImmunotherapeuticsImmunotherapyTumor Biology	2019	21
Impact of Infections in Patients Receiving Pembrolizumab-Based Therapies for Non-Small Cell Lung Cancer Ethan Burns, Kelly Gee, Ryan Blair Kieser, Cancers	2022	11

Page 1